FDA Inspection 1018407 — Bella Pharmaceuticals, Inc.

Bella Pharmaceuticals, Inc. — FEI 3013442632

The FDA completed an inspection of Bella Pharmaceuticals, Inc. on Jul 18, 2017 in Glenview, IL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Jul 18, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glenview, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.